Esperion Therapeutics, Inc. short interest in 2021
In 2021, Esperion Therapeutics, Inc.'s disclosed short interest ran from 39.75% of shares outstanding on 15 Jan 2021 to 29.76% on 31 Dec 2021, a change of -9.99 percentage points. The year's high was 39.75% on 15 Jan 2021 and its low 25.90% on 30 Sep 2021, averaging 32.27% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 26.54 days on 30 Apr 2021. Full history: Esperion Therapeutics, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2021 in figures
- Start of year
- 39.75% (15 Jan 2021)
- End of year
- 29.76% (31 Dec 2021)
- Change
- -9.99 pp
- High
- 39.75% (15 Jan 2021)
- Low
- 25.90% (30 Sep 2021)
- Average
- 32.27%
- Highest days to cover
- 26.54 (30 Apr 2021)
- SEC filings marked
- 10
Every report in 2021
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2021 | 39.75% | 13.73 | results (8-K) |
| 29 Jan 2021 | 36.37% | 7.27 | |
| 12 Feb 2021 | 34.16% | 13.15 | |
| 26 Feb 2021 | 36.17% | 15.75 | 10-K filed, results (8-K) |
| 15 Mar 2021 | 34.94% | 17.90 | |
| 31 Mar 2021 | 33.87% | 18.61 | |
| 15 Apr 2021 | 34.96% | 24.13 | |
| 30 Apr 2021 | 34.67% | 26.54 | |
| 14 May 2021 | 32.40% | 7.08 | 10-Q filed, results (8-K) |
| 28 May 2021 | 31.88% | 12.74 | |
| 15 Jun 2021 | 31.74% | 16.71 | |
| 30 Jun 2021 | 32.04% | 21.45 | |
| 15 Jul 2021 | 33.69% | 15.38 | |
| 30 Jul 2021 | 31.99% | 14.10 | |
| 13 Aug 2021 | 30.85% | 12.07 | 10-Q filed, results (8-K) |
| 31 Aug 2021 | 28.63% | 15.94 | |
| 15 Sep 2021 | 28.80% | 8.64 | |
| 30 Sep 2021 | 25.90% | 7.73 | |
| 15 Oct 2021 | 28.19% | 8.50 | |
| 29 Oct 2021 | 32.47% | 6.80 | results (8-K) |
| 15 Nov 2021 | 30.48% | 6.76 | 10-Q filed, results (8-K) |
| 30 Nov 2021 | 33.97% | 4.55 | |
| 15 Dec 2021 | 26.88% | 1.43 | |
| 31 Dec 2021 | 29.76% | 5.52 |
See also: Esperion Therapeutics, Inc.'s full history · most shorted US stocks of 2021 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.